Skip to content

Effects of Misoprostol versus Tranexamic acid in reduction of postpartum hemorrhage after cesarean

Comparison of the effect of prophylactic misoprostol versus tranexamic acid in reduction of postpartum hemorrhage in candidate patients for cesarean in Amir Al-Momenin hospital, Semnan.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015102511504N6
Enrollment
285
Registered
2015-12-17
Start date
2015-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum hemorrhage. Postpartum haemorrhage

Interventions

Intervention 1: Group A: Cesarean section will do under spinal anesthesia. Patients receive 400 micrograms of misoprostol rectal (as 2 tablets of 200 mcg). Intervention 2: Groupe B: Cesarean section w
Treatment - Drugs
Group A: Cesarean section will do under spinal anesthesia. Patients receive 400 micrograms of misoprostol rectal (as 2 tablets of 200 mcg).
Groupe B: Cesarean section will done under spinal anesthesia. Patients receive Tranexamic acid, 10mg/kg 30 minutes before operation as intravenous infusion during 20 minutes.
Group C: Cesarean section will do under spinal anesthesia. Patients will not receive any treatments except standard and usual therapy.

Sponsors

Vice Chancellor for Research of Semnan University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Candidates for elective cesarean section; gestational age 37 weeks or more; singleton pregnancy with cephalic presentation. Exclusion criteria: Preeclampsia; multiple pregnancies; premature birth; prolonged rupture of the membranes; abnormal placental-binding; systemic diseases; sensitivity to prostaglandins.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Volume of Blood Loss. Timepoint: During surgery. Method of measurement: Measuring of blood lost and counting of blood soaked gauze pieces.

Secondary

MeasureTime frame
Hematocrite and Hemoglubin. Timepoint: 24 horses after surgery. Method of measurement: Laboratory test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Roya Mahdavi Anaraki

Semnan University of Medical Sciences

maryamsina1234@yahoo.com+98 23 3344 0066

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026